West Pharmaceutical Services
WST · NYSE · USD · Healthcare
1What is happening
West Pharmaceutical Services has fallen 9% since its 6-week high on 29/10/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-8.8%
Other view · 15 analystsHorizon: 12 months15 Buy · 0 Hold · 1 Sell2Our assessment
Dip in progress36How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-8.8%
Highest daily price: $438.27 on 29/10/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-8.8%
Highest price in 52 weeks: $438.27 (Yahoo)
Why is it down?
market-wide- ·From its 6-week high of $438.27 on 29/10/2026 the price fell 8.8% to $399.81.
- ·No clear news driver in the last 10 days.
- ·The whole market is down 5.6% from its 60-day high, so part of this is not about the company.
- ·Other Medical Instruments & Supplies stocks we track are down only 5.5% on average, so this is mostly about the company. See all 77 in this sector →
Market-wide drops tend to recover together with the market. The dip score looks at the company on top of that.
What analysts expect
Most of the 15 analysts say buy. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 1594 %
- Hold
- 00 %
- Sell
- 16 %
Average price target$471.00
$340.00 to $500.00 · today $399.81
$340.00Ø $471.00$500.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
Dates
- 10NovEx-dividendBuying from this day no longer gets the next dividend. The price usually drops by about the dividend.
- 18NovDividend paymentThe dividend is paid on this day.
The company in figures
- Market value
- 27.9 bn $
- All shares together at the current price.
- P/E
- 44.9
- Price divided by earnings per share, last 12 months.
- Dividend yield
- 0.26 %
- Yearly dividend relative to the price.
- 52-week range
- $223.83 – $438.27
- Lowest and highest price of the last year.
Catalysts
36 h ago- News, last 10 days
- no recent news
- Next earnings
- —
- Last report
- 29/10/2026 +21.1% vs estimate
Key figures
- Market value
- 27.9 bn $Large cap
- P/E
- 44.9
- Dividend yield
- 0.26 %
- Volume today
- 1.0 × Øabout usual
- Beta
- 1.14swings about like the market
- 52-week range
- $223.83 – $438.27price at 82 % of the range
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
- Headquarters:
- Exton, United States
- 52-week range:
- $223.83 – $438.27
- Website:
- westpharma.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.